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562 Biol Blood Marrow Transplant 16:560–562, 2010Letters to the Editoris an assumed competency from residency, but as stated
in our article [5], the shift in residency education to an
outpatient focus means that such competency should
probably not be presumed, particularly in this erawhere
hospitalists are evolving and arising as the national stan-
dard for inpatient management. These recognitions
emphasize that a broad multidisciplinary collaborative
effort on future HCT patient management may evolve,
which we would welcome.
Currently, HCT fellowships are not ACGME
accredited because they do not lead to an ABMS board
certification. Although some believe the field should
evolve toward board certification, not all current trans-
plant physicians feel that this step is essential, and there
is concern that itwould provide yet anotherbarrier to re-
cruiting physicians to practice in this complex field. Ad-
ditionally, for specialties with small workforces where
the expected numbers of examinees would be fewer
than 50 per year, it is not certain that additional new
board certification would be approved by the national
accrediting body of the American Board of Internal
Medicine or the American Board of Medical Specialties
even if requested. Whether board certification in HCT
wouldmotivate physicians in other disciplines to further
involve themselves in this field when their own field has
a workforce shortage remains unclear.
The ASBMT plans over the next several years to
initiate a series of interventions to address these is-
sues. Plans are underway for ASBMT to publish
a core curriculum for HCT fellowships. To help
HCT practitioners demonstrate continued compe-
tency and to assist with recertification or maintenance
of certification for hematology and medical oncology
boarded practitioners, ASBMT plans to create
a Practice Improvement Module (PIM). ASBMTErratum
In ‘‘Pulmonary, Gonadal, and Central Nervous
System Status after Bone Marrow Transplantation
for Sickle Cell Disease’’ (Walters et al., Biol Blood
Marrow Transplant 2009:16:263–272) the following
author was omitted: Ann Haight, MD, Emory
University, Atlanta, GA.recognizes that the field needs to improve training
and credentialing. These incremental steps will be
a good start. Looking toward more aggressive
recruitment of expertise from other medical disci-
plines may be a new initiative worthy of early, versus
later, exploration.REFERENCES
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